{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:34:46Z","timestamp":1787495686890,"version":"build-2736575974"},"reference-count":128,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The clinical, epidemiological and immunopathological profiles of atypical forms of pemphigus remain only partially known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To define the clinical, epidemiological and immunological characteristics, therapies and outcomes in patients with atypical pemphigus variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a 14-year multicentre retrospective observational study (VARIANT_P) on atypical variants of pemphigus across Italy. We collected demographic, immunopathological and clinical data, as well as information on comorbidities and prescribed treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We enrolled 61 patients [female\/male sex ratio 1.77; 13 paraneoplastic pemphigus (PNP), 26 IgA pemphigus (PIgA), 22 pemphigus herpetiformis (PH)]. The median ages at onset and diagnosis were 70.6 (range 43.1\u201386.8) and 71.1 (range 46.9\u201386.9) for PNP; 62.2 (range 3.8\u201381.0) and 63.6 (range 4.0\u201382.4) for PIgA; and 49.4 (range 5.4\u201384.4) and 52.3 (range 5.9\u201385.9) for PH, respectively. The median diagnostic delay was 3.0 (range 0.0\u201345.6) months for PNP, 9.5 (range 1.0\u2013140.0) months for PIgA and 2.0 (range 0\u201330.4) months for PH. The mortality rate was 55% (6\/11) for PNP, 4% (1\/26) for PIgA and 6% (1\/17) for PH. Cutaneous involvement was present in all patients with PIgA and PH, and in 83% (10\/12) of the patients with PNP. In contrast, oral mucosal involvement was observed in all patients with PNP with data (n = 12), but only in 8% (2\/26) of those with PIgA and 21% (4\/19) of those with PH. Histology, direct immunofluorescence, indirect immunofluorescence and enzyme-linked immunosorbent assay data demonstrated variable concordance with previously known data. Comorbidities included mainly solid malignancies for people with PNP, whereas cardiovascular and metabolic diseases were the most prevalent for those with PIgA and PH. Treatment mostly relied on systemic steroids and rituximab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The VARIANT_P study contributes to data collection relating to atypical pemphigus variants in order to promote the development of specific therapeutical guidelines in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ced\/llaf438","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:53:10Z","timestamp":1759492390000},"page":"250-262","source":"Crossref","is-referenced-by-count":2,"title":["A 14-year multicentric follow-up study of atypical pemphigus variants in Italy: the VARIANT_P study"],"prefix":"10.1093","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9228-8042","authenticated-orcid":false,"given":"Lavinia","family":"Quintarelli","sequence":"first","affiliation":[{"name":"Rare Skin Diseases Unit, Section of Dermatology, Department of Health Sciences, ERN-SKIN Member, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8253-4127","authenticated-orcid":false,"given":"Irene","family":"Bonanni","sequence":"additional","affiliation":[{"name":"Rare Skin Diseases Unit, Section of Dermatology, Department of Health Sciences, ERN-SKIN Member, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0388-1037","authenticated-orcid":false,"given":"Elena Biancamaria","family":"Mariotti","sequence":"additional","affiliation":[{"name":"Rare Skin Diseases Unit, Section of Dermatology, Department of Health Sciences, ERN-SKIN Member, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-1402","authenticated-orcid":false,"given":"Laura","family":"Atzori","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department Medical Sciences and Public Health, University of Cagliari , Cagliari ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0898-0045","authenticated-orcid":false,"given":"Clara","family":"De Simone","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-6714","authenticated-orcid":false,"given":"Camilla","family":"Vassallo","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo , Pavia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6106-599X","authenticated-orcid":false,"given":"Giovanni","family":"Di Zenzo","sequence":"additional","affiliation":[{"name":"Molecular and Cell Biology Laboratory, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7433-9283","authenticated-orcid":false,"given":"Stefano","family":"Caccavale","sequence":"additional","affiliation":[{"name":"Unit of Dermatology, University of Campania Luigi Vanvitelli , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3108-4123","authenticated-orcid":false,"given":"Emanuele","family":"Cozzani","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Health Sciences (DISSAL), University of Genoa, IRCCS Ospedale Policlinico San Martino , Genoa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8548-0493","authenticated-orcid":false,"given":"Gianpiero","family":"Girolomoni","sequence":"additional","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine, University of Verona , Verona ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-4169","authenticated-orcid":false,"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4848-3817","authenticated-orcid":false,"given":"Andrea","family":"Conti","sequence":"additional","affiliation":[{"name":"Dermatologic Unit, Department of Surgery, Infermi Hospital of Rimini , auSL Romagna, Rimini ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Vezzoli","sequence":"additional","affiliation":[{"name":"Dermatology Unit, ASST Papa Giovanni XXIII , Bergamo ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2390-6505","authenticated-orcid":false,"given":"Giovanni","family":"Damiani","sequence":"additional","affiliation":[{"name":"Clinical Dermatology, IRCCS Istituto Ortopedico Galeazzi-Sant'Ambrogio , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8961-7108","authenticated-orcid":false,"given":"Vito","family":"Di Lernia","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia , Reggio Emilia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Balestri","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Outpatient Consultation for Rare Diseases, APSS , Trento ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Maglie","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Health Sciences, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0903-4998","authenticated-orcid":false,"given":"Alberto","family":"Corr\u00e0","sequence":"additional","affiliation":[{"name":"Rare Skin Diseases Unit, Section of Dermatology, Department of Health Sciences, ERN-SKIN Member, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1701-8772","authenticated-orcid":false,"given":"Alessandro","family":"Magnatta","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Health Sciences, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9996-2896","authenticated-orcid":false,"given":"Marta","family":"Donati","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia , Reggio Emilia ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0307-6636","authenticated-orcid":false,"given":"Valentina","family":"Ruffo di Calabria","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Health Sciences, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1982-888X","authenticated-orcid":false,"given":"Alice","family":"Verdelli","sequence":"additional","affiliation":[{"name":"Rare Skin Diseases Unit, Section of Dermatology, Department of Health Sciences, ERN-SKIN Member, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-3144","authenticated-orcid":false,"given":"Alessio","family":"Coi","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology, National Research Council , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7787-4433","authenticated-orcid":false,"given":"Emiliano","family":"Antiga","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Health Sciences, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7471-3471","authenticated-orcid":false,"given":"Marzia","family":"Caproni","sequence":"additional","affiliation":[{"name":"Rare Skin Diseases Unit, Section of Dermatology, Department of Health Sciences, ERN-SKIN Member, University of Florence , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"2026012711330115700_llaf438-B1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"2026012711330115700_llaf438-B2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clindermatol.2011.01.013","article-title":"Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis)","volume":"29","author":"Joly","year":"2011","journal-title":"Clin Dermatol"},{"key":"2026012711330115700_llaf438-B3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1440-0960.2005.00191.x","article-title":"Comparison of desmoglein ELISA and indirect immunofluorescence using two substrates (monkey oesophagus and normal human skin) in the diagnosis of pemphigus","volume":"46","author":"Ng","year":"2005","journal-title":"Australas J Dermatol"},{"key":"2026012711330115700_llaf438-B4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/1523-1747.ep12337524","article-title":"Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles","volume":"109","author":"Ding","year":"1997","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B6","first-page":"529","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Tron","year":"2009","journal-title":"Arch Dermatol"},{"key":"2026012711330115700_llaf438-B7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamadermatol.2023.5679","article-title":"Sustained remission without corticosteroids among patients with pemphigus who had rituximab as first-line therapy: follow-up of the Ritux 3 trial","volume":"160","author":"Tedbirt","year":"2024","journal-title":"JAMA Dermatol"},{"key":"2026012711330115700_llaf438-B8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-4362.1990.tb02571.x","article-title":"Beau\u2019s lines and pemphigus vulgaris","volume":"29","author":"Lauber","year":"1990","journal-title":"Int J Dermatol"},{"key":"2026012711330115700_llaf438-B9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0190-9622(99)70161-1","article-title":"Making sense of antigens and antibodies in pemphigus","volume":"40","author":"Anhalt","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1172\/JCI5252","article-title":"Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris","volume":"103","author":"Mahoney","year":"1999","journal-title":"J Clin Invest"},{"key":"2026012711330115700_llaf438-B11","first-page":"598","article-title":"Clinical and immunopathological spectrum of paraneoplastic pemphigus","volume":"8","author":"Zimmermann","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026012711330115700_llaf438-B12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/CCID.S100802","article-title":"Paraneoplastic pemphigus: a short review","volume":"9","author":"Wieczorek","year":"2016","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026012711330115700_llaf438-B13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1523-1747.1998.00280.x","article-title":"Autoantibodies from a patient with paraneoplastic pemphigus bind periplakin, a novel member of the plakin family","volume":"111","author":"Borradori","year":"1998","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1523-1747.1998.00279.x","article-title":"The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin","volume":"111","author":"Mahoney","year":"1998","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B15","doi-asserted-by":"crossref","first-page":"e12250","DOI":"10.1371\/journal.pone.0012250","article-title":"The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human","volume":"5","author":"Schepens","year":"2010","journal-title":"PLoS One"},{"key":"2026012711330115700_llaf438-B16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"key":"2026012711330115700_llaf438-B17","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/jid.2013.65","article-title":"Anti-\u03b1-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus","volume":"133","author":"Numata","year":"2013","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B18","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1172\/JCI115781","article-title":"Human autoantibodies against desmoplakins in paraneoplastic pemphigus","volume":"89","author":"Oursler","year":"1992","journal-title":"J Clin Invest"},{"key":"2026012711330115700_llaf438-B19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin Chim Acta"},{"key":"2026012711330115700_llaf438-B20","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1046\/j.1523-1747.1998.00449.x","article-title":"Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex","volume":"111","author":"Kiyokawa","year":"1998","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/1523-1747.ep12336235","article-title":"cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex","volume":"109","author":"Kim","year":"1997","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1523-1747.1999.00498.x","article-title":"Human autoantibodies against HD1\/plectin in paraneoplastic pemphigus","volume":"112","author":"Proby","year":"1999","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/JID.2015.408","article-title":"Epiplakin is a paraneoplastic pemphigus autoantigen and related to bronchiolitis obliterans in Japanese patients","volume":"136","author":"Tsuchisaka","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/bjd.13711","article-title":"Anti-desmocollin autoantibodies in nonclassical pemphigus","volume":"173","author":"Ishii","year":"2015","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B25","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archdermatol.2012.1830","article-title":"Prognostic factors of paraneoplastic pemphigus","volume":"148","author":"Leger","year":"2012","journal-title":"Arch Dermatol"},{"key":"2026012711330115700_llaf438-B26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0896-8411(02)00092-6","article-title":"Paraneoplastic pemphigus is associated with the DRB1*03 allele","volume":"20","author":"Martel","year":"2003","journal-title":"J Autoimmun"},{"key":"2026012711330115700_llaf438-B27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0190-9622(95)90269-4","article-title":"Paraneoplastic pemphigus in the absence of a known neoplasm","volume":"33","author":"Ostezan","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B29","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch Dermatol"},{"key":"2026012711330115700_llaf438-B30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1087-0024.2004.00832.x","article-title":"Paraneoplastic pemphigus","volume":"9","author":"Anhalt","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2026012711330115700_llaf438-B31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1440-0960.2012.00921.x","article-title":"Paraneoplastic pemphigus","volume":"54","author":"Yong","year":"2013","journal-title":"Australas J Dermatol"},{"key":"2026012711330115700_llaf438-B32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2007.00322.x","article-title":"Paraneoplastic pemphigus","volume":"34","author":"Zhu","year":"2007","journal-title":"J Dermatol"},{"key":"2026012711330115700_llaf438-B33","doi-asserted-by":"crossref","first-page":"NP69","DOI":"10.1177\/11206721211033465","article-title":"Paraneoplastic pemphigus associated with rapidly progressing endophthalmitis caused by Morganella Morganii: a case report","volume":"32","author":"Almater","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"2026012711330115700_llaf438-B34","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.12.2008.1306","article-title":"Paraneoplastic pemphigus: an uncommon cause of chronic cicatrising conjunctivitis","volume":"2009","author":"Tam","year":"2009","journal-title":"BMJ Case Rep"},{"key":"2026012711330115700_llaf438-B35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ophtha.2009.09.006","article-title":"Paraneoplastic conjunctival cicatrization: two different pathogenic types","volume":"117","author":"Ahuero","year":"2010","journal-title":"Ophthalmology"},{"key":"2026012711330115700_llaf438-B36","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/09273948.2020.1828491","article-title":"Paraneoplastic pemphigus associated with bilateral corneal perforations in follicular dendritic cell sarcoma","volume":"30","author":"Venkateswaran","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"2026012711330115700_llaf438-B37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/09273948.2016.1203958","article-title":"Ocular onset of paraneoplastic pemphigus presenting as hyperemic conjunctivitis and massive bilateral eyelid ulceration: a case report and literature review","volume":"26","author":"Piscopo","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"2026012711330115700_llaf438-B38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000051622","article-title":"Bilateral corneal melting in a patient with paraneoplastic pemphigus","volume":"202","author":"Beele","year":"2001","journal-title":"Dermatol Basel Switz"},{"key":"2026012711330115700_llaf438-B39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12886-016-0280-7","article-title":"Recurrent corneal melting in the paraneoplastic pemphigus associated with Castleman\u2019s disease","volume":"16","author":"Gong","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"2026012711330115700_llaf438-B40","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1346-8138.2010.01192.x","article-title":"Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: a case report and review of cases treated with rituximab","volume":"38","author":"Anan","year":"2011","journal-title":"J\u00a0Dermatol"},{"key":"2026012711330115700_llaf438-B41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1440-1843.2008.01397.x","article-title":"Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome","volume":"14","author":"Maldonado","year":"2009","journal-title":"Respirology"},{"key":"2026012711330115700_llaf438-B42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00277-021-04499-8","article-title":"Fatal progression of bronchiolitis obliterans in spite of complete remission of follicular lymphoma and paraneoplastic pemphigus","volume":"101","author":"Kishi","year":"2022","journal-title":"Ann Hematol"},{"key":"2026012711330115700_llaf438-B43","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jaad.2018.03.043","article-title":"Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults","volume":"80","author":"Ouedraogo","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2133.2002.04992.x","article-title":"Paraneoplastic pemphigus in children and adolescents","volume":"147","author":"Mimouni","year":"2002","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B45","first-page":"100004","article-title":"Epidemiology of pemphigus","volume":"1","author":"Kridin","year":"2021","journal-title":"JID Innov Skin Sci Mol Popul Health"},{"key":"2026012711330115700_llaf438-B46","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3389\/fimmu.2018.00994","article-title":"Clinical and immunological study of 30 cases with both IgG and IgA anti-keratinocyte cell surface autoantibodies toward the definition of intercellular IgG\/IgA dermatosis","volume":"9","author":"Hashimoto","year":"2018","journal-title":"Front Immunol"},{"key":"2026012711330115700_llaf438-B47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1590\/abd1806-4841.20142459","article-title":"Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG\/IgA pemphigus","volume":"89","author":"Porro","year":"2014","journal-title":"An Bras Dermatol"},{"key":"2026012711330115700_llaf438-B48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2133.2000.03604.x","article-title":"Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review","volume":"143","author":"Yasuda","year":"2000","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/1523-1747.ep12613668","article-title":"Adhesion molecules. I: keratinocyte-keratinocyte interactions; cadherins and pemphigus","volume":"104","author":"Amagai","year":"1995","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.clindermatol.2011.01.014","article-title":"IgA pemphigus","volume":"29","author":"Tsuruta","year":"2011","journal-title":"Clin Dermatol"},{"key":"2026012711330115700_llaf438-B51","volume-title":"[Clinical Immunodermatology]","author":"Fabbri","year":"2023"},{"key":"2026012711330115700_llaf438-B52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjd.12940","article-title":"The expanding spectrum of IgA pemphigus: a case report and review of the literature","volume":"171","author":"Geller","year":"2014","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2230.1990.tb02138.x","article-title":"The clinical and histopathological spectrum of IgA-pemphigus \u2013 report of two cases","volume":"15","author":"Hodak","year":"1990","journal-title":"Clin Exp Dermatol"},{"key":"2026012711330115700_llaf438-B54","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0190-9622(92)70301-U","article-title":"Intraepidermal IgA pustulosis","volume":"27","author":"Wallach","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clindermatol.2011.03.006","article-title":"Autoimmune bullous diseases associations","volume":"30","author":"Ljubojevic","year":"2012","journal-title":"Clin Dermatol"},{"key":"2026012711330115700_llaf438-B56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2340\/00015555-1658","article-title":"Overlap of IgA pemphigus and linear IgA dermatosis in a patient with ulcerative colitis: a mere coincidence?","volume":"94","author":"Kern","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"2026012711330115700_llaf438-B57","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjd.13872","article-title":"Immunobullous disease and ulcerative colitis: a case series of six patients","volume":"173","author":"Sotiriou","year":"2015","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B58","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1111\/jdv.14436","article-title":"Intraepidermal neutrophilic dermatosis type of IgA pemphigus with circulating linear IgA disease antibodies associated with ulcerative colitis","volume":"32","author":"Papakonstantinou","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026012711330115700_llaf438-B59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/dth.12126","article-title":"Management of a pemphigus with IgA and IgG antibodies and coexistent lung cancer","volume":"27","author":"Cetkovsk\u00e1","year":"2014","journal-title":"Dermatol Ther"},{"key":"2026012711330115700_llaf438-B60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1346-8138.2008.00481.x","article-title":"Immunoglobulin A pemphigus associated with immunoglobulin A gammopathy and lung cancer","volume":"35","author":"Petropoulou","year":"2008","journal-title":"J Dermatol"},{"key":"2026012711330115700_llaf438-B61","doi-asserted-by":"crossref","first-page":"e05567","DOI":"10.1002\/ccr3.5567","article-title":"Pemphigus herpetiformis in a 4-year-old child: case report and review of the literature","volume":"10","author":"Hayder","year":"2022","journal-title":"Clin Case Rep"},{"key":"2026012711330115700_llaf438-B62","doi-asserted-by":"crossref","first-page":"712560","DOI":"10.5402\/2011\/712560","article-title":"A case of pemphigus herpetiformis in a 12-year-old male","volume":"2011","author":"Hocar","year":"2011","journal-title":"ISRN Pediatr"},{"key":"2026012711330115700_llaf438-B63","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1525-1470.2012.01746.x","article-title":"A case of pemphigus herpetiformis occurring in a 9-year-old boy","volume":"30","author":"Leithauser","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"2026012711330115700_llaf438-B64","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5070\/D36677332S","article-title":"Letter: pemphigus herpetiformis of age of onset at 6\u2005years","volume":"17","author":"Moutran","year":"2011","journal-title":"Dermatol Online J"},{"key":"2026012711330115700_llaf438-B65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-4362.1975.tb00125.x","article-title":"Herpetiform pemphigus, a variable pattern of pemphigus","volume":"14","author":"Jablonska","year":"1975","journal-title":"Int J Dermatol"},{"key":"2026012711330115700_llaf438-B66","first-page":"128","article-title":"A case of clinically typical dermatitis herpetiformis (MB Duhring) presenting acantholysis","volume":"35","author":"Floden","year":"1955","journal-title":"Acta Derm Venereol"},{"key":"2026012711330115700_llaf438-B67","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1525-1470.2010.01256.x","article-title":"Pemphigus herpetiformis in childhood","volume":"27","author":"Duarte","year":"2010","journal-title":"Pediatr Dermatol"},{"issue":"Suppl. 1","key":"2026012711330115700_llaf438-B68","first-page":"AB145","article-title":"A case of pemphigus herpetiformis in a 10-year-old female","volume":"60","author":"Adams","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B69","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1080\/15569527.2016.1254650","article-title":"Pemphigus herpetiformis-type drug reaction caused by erdosteine containing mucolytic in a child","volume":"36","author":"Akoglu","year":"2017","journal-title":"Cutan Ocul Toxicol"},{"key":"2026012711330115700_llaf438-B70","first-page":"154","article-title":"Childhood pemphigus foliaceus. Herpetiform variant","volume":"13","author":"Bonifazi","year":"2003","journal-title":"Eur J Pediatr Dermatol"},{"key":"2026012711330115700_llaf438-B71","first-page":"499","article-title":"Pemphigus herpetiformis resistant to first line therapy: a rare case in childhood","volume":"154","author":"Maggiore","year":"2019","journal-title":"G Ital Dermatol E Venereol"},{"key":"2026012711330115700_llaf438-B72","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1111\/pde.12649","article-title":"Transplacental transmission of pemphigus herpetiformis in the setting of maternal lymphoma","volume":"32","author":"Schoch","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"2026012711330115700_llaf438-B73","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/pde.13152","article-title":"Pediatric pemphigus herpetiformis: case report and review of the literature","volume":"34","author":"Peterman","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"2026012711330115700_llaf438-B74","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-0560.1996.tb01477.x","article-title":"Neutrophilic spongiosis in pemphigus herpetiformis","volume":"23","author":"Huhn","year":"1996","journal-title":"J Cutan Pathol"},{"key":"2026012711330115700_llaf438-B75","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.jaad.2009.09.016","article-title":"Antidesmocollin-1 antibody-positive, antidesmoglein antibody-negative pemphigus herpetiformis","volume":"63","author":"Tateishi","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B76","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jamadermatol.2013.1916","article-title":"Coexistence of pemphigus herpetiformis with IgG antibodies to desmocollin 1 and pemphigoid with IgG antibodies to BP180 C-terminal domain and laminin \u03b32","volume":"149","author":"Ohata","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2026012711330115700_llaf438-B77","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","article-title":"Epitope spreading: lessons from autoimmune skin diseases","volume":"110","author":"Chan","year":"1998","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B78","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2133.1994.tb02908.x","article-title":"Thiopronine-induced herpetiform pemphigus: report of a case studied by immunoelectron microscopy and immunoblot analysis","volume":"130","author":"Verdier-Sevrain","year":"1994","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B79","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2336\/nishinihonhifu.65.126","article-title":"A case of D-penicillamine induced herpetiform pemphigus","volume":"65","author":"Abe","year":"2003","journal-title":"Nishinihon J Dermatol"},{"key":"2026012711330115700_llaf438-B80","first-page":"587","article-title":"Pemphigus herpetiformis following D-penicillamine in a patient with HLA B8","volume":"39","author":"Weltfriend","year":"1988","journal-title":"Hautarzt"},{"key":"2026012711330115700_llaf438-B81","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2133.1977.tb14257.x","article-title":"Herpetiform pemphigus induced by penicillamine","volume":"97","author":"Marsden","year":"1977","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B82","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/bjd.12925","article-title":"Clinical and immunological profiles in 17 Japanese patients with drug-induced pemphigus studied at Kurume University","volume":"171","author":"Yoshimura","year":"2014","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B83","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1346-8138.1980.tb01996.x","article-title":"Herpetiform pemphigus-like skin lesions induced by D-penicillamine","volume":"7","author":"Morioka","year":"1980","journal-title":"J Dermatol"},{"key":"2026012711330115700_llaf438-B84","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaad.2013.11.043","article-title":"Pemphigus herpetiformis: from first description until now","volume":"70","author":"Kasperkiewicz","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B85","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/ijd.14395","article-title":"Clinical, pathologic, and immunologic features of pemphigus herpetiformis: a literature review and proposed diagnostic criteria","volume":"58","author":"Costa","year":"2019","journal-title":"Int J Dermatol"},{"key":"2026012711330115700_llaf438-B86","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0190-9622(99)70145-3","article-title":"The new pemphigus variants","volume":"40","author":"Robinson","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B87","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archdermatol.2010.362","article-title":"Paraneoplastic pemphigus herpetiformis with IgG antibodies to desmoglein 3 and without mucosal lesions","volume":"147","author":"Prado","year":"2011","journal-title":"Arch Dermatol"},{"key":"2026012711330115700_llaf438-B88","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/000155502320323333","article-title":"Herpetiformis pemphigus and lung carcinoma: a case of paraneoplastic pemphigus","volume":"82","author":"Palleschi","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"2026012711330115700_llaf438-B89","first-page":"119","article-title":"Herpetiform pemphigus associated with esophageal carcinoma","volume":"96","author":"Arranz","year":"2005","journal-title":"Actas Dermosifiliogr"},{"key":"2026012711330115700_llaf438-B90","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1468-3083.2006.01992.x","article-title":"Pemphigus herpetiformis associated with prostate cancer","volume":"21","author":"Marzano","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026012711330115700_llaf438-B91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1346-8138.2011.01287.x","article-title":"Pemphigus herpetiformis in a patient with well-differentiated cutaneous angiosarcoma: case report and review of the published work","volume":"39","author":"Lu","year":"2012","journal-title":"J Dermatol"},{"key":"2026012711330115700_llaf438-B92","first-page":"63","article-title":"A case of herpetiform pemphigus associated with lung cancer","volume":"83","author":"Yamamoto","year":"1988","journal-title":"Acta Dermatol Kyoto"},{"key":"2026012711330115700_llaf438-B93","first-page":"373","article-title":"Pemphigus herpetiformis associated with neoplasm of the lung","volume":"17","author":"Vicente","year":"1989","journal-title":"Med Cutan Ibero Lat Am"},{"key":"2026012711330115700_llaf438-B94","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1346-8138.1994.tb01803.x","article-title":"A case of herpetiform pemphigus associated with lung cancer","volume":"21","author":"Kubota","year":"1994","journal-title":"J Dermatol"},{"key":"2026012711330115700_llaf438-B95","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2230.1994.tb01114.x","article-title":"Autoimmune blistering diseases associated with HIV infection","volume":"19","author":"Bull","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"2026012711330115700_llaf438-B96","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.0303-6987.2004.0188.x","article-title":"Development of pemphigus herpetiformis in a patient with psoriasis receiving UV-light treatment","volume":"31","author":"Sanchez-Palacios","year":"2004","journal-title":"J Cutan Pathol"},{"key":"2026012711330115700_llaf438-B97","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-2133.1999.03129.x","article-title":"A case of herpetiform pemphigus coexisting with psoriasis vulgaris","volume":"141","author":"Morita","year":"1999","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B98","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1468-3083.2003.00738.x","article-title":"Coexistence of pemphigus herpetiformis and systemic lupus erythematosus","volume":"17","author":"Marinovi\u0107","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026012711330115700_llaf438-B99","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000246354","article-title":"A case of herpetiform pemphigus associated with autoimmune hemolytic anemia: detection of autoantibodies against multiple epidermal antigens","volume":"192","author":"Shimizu","year":"1996","journal-title":"Dermatol Basel Switz"},{"key":"2026012711330115700_llaf438-B100","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/bjd.13088","article-title":"A case of pemphigus herpetiformis-like atypical pemphigus with IgG anti-desmocollin 3 antibodies","volume":"171","author":"Nakamura","year":"2014","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000251246","article-title":"Coexistence of peculiar pemphigus, myasthenia gravis and malignant thymoma","volume":"152","author":"Tagami","year":"1976","journal-title":"Dermatologica"},{"key":"2026012711330115700_llaf438-B102","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/ced.13318","article-title":"Coexistence of pemphigus herpetiformis with extramammary Paget disease","volume":"43","author":"Wang","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"2026012711330115700_llaf438-B103","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2230.2009.03525.x","article-title":"Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype","volume":"35","author":"Lebeau","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"2026012711330115700_llaf438-B104","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/jdv.18931","article-title":"S2k guidelines on the management of paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"37","author":"Antiga","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026012711330115700_llaf438-B105","volume-title":"Stata Statistical Software Release 16","author":"StataCorp","year":"2019"},{"key":"2026012711330115700_llaf438-B106","doi-asserted-by":"crossref","first-page":"895490","DOI":"10.3389\/fimmu.2022.895490","article-title":"Clinical patterns, survival, comorbidities, and treatment regimens in 149 patients with pemphigus in Tuscany (Italy): a 12-year hospital-based study","volume":"13","author":"Quintarelli","year":"2022","journal-title":"Front Immunol"},{"key":"2026012711330115700_llaf438-B107","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jaad.2019.11.059","article-title":"IgA pemphigus: a systematic review","volume":"82","author":"Kridin","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B108","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jdv.16752","article-title":"Updated S2\u2005K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"34","author":"Joly","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2026012711330115700_llaf438-B109","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet"},{"key":"2026012711330115700_llaf438-B110","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-4632.2011.04868.x","article-title":"Paraneoplastic autoimmune multiorgan syndrome: 20\u2005years after","volume":"50","author":"Czernik","year":"2011","journal-title":"Int J Dermatol"},{"key":"2026012711330115700_llaf438-B111","doi-asserted-by":"crossref","first-page":"adv00312","DOI":"10.2340\/00015555-3673","article-title":"Features and risk factors for paraneoplastic autoimmune multiorgan syndrome in 145 Chinese patients","volume":"100","author":"Wang","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"2026012711330115700_llaf438-B112","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/ijms18122532","article-title":"Paraneoplastic pemphigus: insight into the autoimmune pathogenesis, clinical features and therapy","volume":"18","author":"Paolino","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2026012711330115700_llaf438-B113","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.annder.2018.01.050","article-title":"Paraneoplastic pemphigus: retrospective study of a case series","volume":"145","author":"Fournet","year":"2018","journal-title":"Ann Dermatol Venereol"},{"key":"2026012711330115700_llaf438-B114","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1111\/ijd.14056","article-title":"Paraneoplastic pemphigus in Russian patients: a single center case series","volume":"57","author":"Allenova","year":"2018","journal-title":"Int J Dermatol"},{"key":"2026012711330115700_llaf438-B115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B116","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/bjd.14282","article-title":"Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus","volume":"174","author":"Poot","year":"2016","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B117","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.autrev.2018.04.008","article-title":"Paraneoplastic autoimmune multiorgan syndrome (PAMS): beyond the single phenotype of paraneoplastic pemphigus","volume":"17","author":"Amber","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2026012711330115700_llaf438-B118","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(95)90066-7","article-title":"Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus","volume":"32","author":"Helou","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"2026012711330115700_llaf438-B119","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/jid.2014.151","article-title":"Immunological and statistical studies of anti-BP180 antibodies in paraneoplastic pemphigus","volume":"134","author":"Tsuchisaka","year":"2014","journal-title":"J Invest Dermatol"},{"key":"2026012711330115700_llaf438-B120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5826\/dpc.0604a07","article-title":"IgA pemphigus showing IgA antibodies to desmoglein 1 and 3","volume":"6","author":"Hegazy","year":"2016","journal-title":"Dermatol Pract Concept"},{"key":"2026012711330115700_llaf438-B121","first-page":"1901","article-title":"Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis","volume":"150","author":"Wang","year":"1997","journal-title":"Am J Pathol"},{"key":"2026012711330115700_llaf438-B122","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1034\/j.1600-0625.2000.009003224.x","article-title":"Identification of desmoglein 1 as autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus","volume":"9","author":"K\u00e1rp\u00e1ti","year":"2000","journal-title":"Exp Dermatol"},{"key":"2026012711330115700_llaf438-B123","doi-asserted-by":"crossref","first-page":"456","DOI":"10.23736\/S2784-8671.22.07217-6","article-title":"IgA pemphigus and Sneddon Wilkinson disease: a spectrum of diseases?","volume":"157","author":"Aimo","year":"2022","journal-title":"Ital J Dermatol Venereol"},{"key":"2026012711330115700_llaf438-B124","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.det.2023.08.010","article-title":"Superficial and bullous neutrophilic dermatoses: Sneddon-Wilkinson, IgA pemphigus, and bullous lupus","volume":"42","author":"Manjaly","year":"2024","journal-title":"Dermatol Clin"},{"key":"2026012711330115700_llaf438-B125","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1365-2133.1999.03209.x","article-title":"Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression","volume":"141","author":"Miyagawa","year":"1999","journal-title":"Br J Dermatol"},{"key":"2026012711330115700_llaf438-B126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1346-8138.2004.tb00693.x","article-title":"A case of herpetiform pemphigus with anti-desmoglein 3 IgG autoantibodies","volume":"31","author":"Isogai","year":"2004","journal-title":"J Dermatol"},{"key":"2026012711330115700_llaf438-B127","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archderm.135.8.943","article-title":"Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus","volume":"135","author":"Ishii","year":"1999","journal-title":"Arch Dermatol"},{"key":"2026012711330115700_llaf438-B128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2133.1997.17781865.x","article-title":"Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3)","volume":"137","author":"Kubo","year":"1997","journal-title":"Br J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf438\/64631464\/llaf438.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/2\/250\/64631464\/llaf438.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/51\/2\/250\/64631464\/llaf438.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:33:26Z","timestamp":1769531606000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/51\/2\/250\/8281747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":128,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,10,13]]},"published-print":{"date-parts":[[2026,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf438","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,10,13]]}}}